ACSoMP Terms of Reference

The Advisory Committee on Safety of Medicinal Products shall provide advice to the Director-General and as appropriate through him to the Collaborating Centre for International Drug Monitoring (the Uppsala Monitoring Centre), and to the Member States of WHO, on pharmacovigilance policy and issues related to the safety and effectiveness of medicinal products.